These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Challenges in the therapy of HIV infection. Yarchoan R; Mitsuya H; Broder S Trends Pharmacol Sci; 1993 May; 14(5):196-202. PubMed ID: 8212316 [TBL] [Abstract][Full Text] [Related]
3. Implications of the discovery of HTLV-III for the treatment of AIDS. Yarchoan R; Mitsuya H; Matsushita S; Broder S Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models. Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334 [TBL] [Abstract][Full Text] [Related]
7. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection. Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726 [TBL] [Abstract][Full Text] [Related]
8. In search of specific inhibitors of retrovirus replication. De Clercq E; Balzarini J Antiviral Res; 1985; Suppl 1():89-94. PubMed ID: 2417552 [No Abstract] [Full Text] [Related]
9. [Inhibition of the avian leukosis-sarcoma complex with 3'-azido-3'-deoxythymidine (AzT); a model for screening and evaluation of chemotherapeutic agents against retrovirus infections]. Kavsan VM; Rudenko NK; Shneĭder MA; Kraevskiĭ AA; Bibilashvili RSh Dokl Akad Nauk SSSR; 1987; 296(6):1492-7. PubMed ID: 2448108 [No Abstract] [Full Text] [Related]
10. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo. Ott DE; Hewes SM; Alvord WG; Henderson LE; Arthur LO Virology; 1998 Apr; 243(2):283-92. PubMed ID: 9568028 [TBL] [Abstract][Full Text] [Related]
11. Update on antiretroviral agents other than zidovudine. Johnson RP; Schooley RT AIDS; 1989; 3 Suppl 1():S145-51. PubMed ID: 2482054 [No Abstract] [Full Text] [Related]
12. Targets for antiviral therapy of human immunodeficiency virus infection. Jeffries DJ J Infect; 1989 Jan; 18 Suppl 1():5-13. PubMed ID: 2464649 [TBL] [Abstract][Full Text] [Related]
13. Challenges in the therapy of HIV infection. Yarchoan R; Mitsuya H; Broder S Immunol Today; 1993 Jun; 14(6):303-9. PubMed ID: 8397771 [TBL] [Abstract][Full Text] [Related]
14. Animal lentivirus replication and reverse transcriptase inhibitors. Beaussoleil S; Bosgiraud C; Nicolas JA Rev Infect Dis; 1989; 11(5):732-40. PubMed ID: 2479076 [TBL] [Abstract][Full Text] [Related]
15. The Seventh Conference on Retroviruses and Opportunistic Infections. Merrick S; Gulick R; Boyle B AIDS Read; 2000 Mar; 10(3):135-9. PubMed ID: 10758009 [No Abstract] [Full Text] [Related]
16. Synergistic combinations and peptides in the inhibition of human immunodeficiency virus. Cox S; Koshida R; Harmenberg J; Wahren B Adv Enzyme Regul; 1991; 31():85-97. PubMed ID: 1715118 [TBL] [Abstract][Full Text] [Related]